[A case of complete regression of liver metastases by treatment with Futraful supposition].
The patient was a 57-year-old man abnormalities indicated in examinations by X-ray and ultrasonography in February, 1991. X-ray and endoscopic examination revealed a Borrmann type 3 carcinoma in the posterior wall and lesser curvature of the upper body of the stomach. The liver was swollen to 3 fingerbreadths on the right mid-clavicular line. Multiple liver metastases were revealed by computed tomography (CT). Proximal gastrectomy was done. From March 24, 1991, a Futraful suppository (1,500 mg/day) was given daily. After 4 months, CT showed the reduction and partial disappearance of the low-density areas of the liver. After 2 years and 7 months, CT showed very small low-density areas, which completely disappeared by April, 1998. The patient has had a good quality of life. According to the General Rules for Gastric Cancer Study, the patient belongs to the class of complete response.
Noji
M
M
Dept. of Gastroenterological Surgery, Japan Red Cross Medical Center.
Bandoh
T
T
Isoyama
T
T
Nagaoka
S
S
Fujiwara
M
M
Takemura
T
T
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D013488:Suppositories; D005641:Tegafur / Q000008:administration & dosage*
D000964:Antimetabolites, Antineoplastic; D013488:Suppositories; D005641:Tegafur